Effect of supplementation with an electrolyte containing a Bacillus-based direct-fed microbial on immune development in dairy calves.

Immune characteristics in 65 calves were evaluated in response to a Bacillus-based direct-fed microbial (DFM) provided in electrolyte scour treatment. Blood samples were analyzed for cell surface markers and α(1)-acid glycoprotein (AGP) concentration. AGP increased in scouring calves given electrolyte containing Bacillus at day 7 post-placement compared to scouring calves administered electrolyte alone and non-scouring calves, enhancing the inflammatory response for pathogen clearance. The Bacillus promotes T cell subsets including greater proportions of activated, mature cells (CD8(-)CD25(+), CD8(-)CD45RO(+), CD8(-)TCR1(+)) in calves given electrolyte containing Bacillus than scouring calves administered electrolyte alone and non-scouring calves. Also, the Bacillus may be alleviating inflammation at day 3 post-placement as the proportion of monocytes and granulocytes lacking L-selectin (CD172a(+)CD62L(-)) was greater in scouring calves given electrolyte compared to the other groups. Electrolyte containing Bacillus administered at the onset of scours influences components of innate and adaptive immune development during and following the scouring event.

Benefits of Supplementation of an Electrolyte Scour Treatment with a Bacillus-Based Direct-Fed Microbial for Calves.

A Bacillus-based direct-fed microbial (DFM), Omni-BosCB™, added to an electrolyte was evaluated as a therapy for scours. Fecal shedding of presumptive Clostridium perfringens at day 7 was reduced in scouring calves treated with electrolyte plus DFM compared to scouring calves treated with electrolyte alone. Total therapeutic treatment costs during the first 2 weeks were significantly reduced by supplementing the electrolyte with the DFM: $18.69 and $21.57 for electrolyte plus DFM and electrolyte treated calves, respectively. Electrolyte treated calves experienced more severe scours than electrolyte plus DFM treated calves as additional therapy with Lactated Ringer's Solution was only necessary for electrolyte treated calves. The DFM may have other ancillary benefits after supplementation has ended, as evidenced by decreased recurrence of a second scouring event. This is the first report demonstrating efficacy of a DFM used therapeutically for mitigating calf scours. These findings have implications as alternatives to chemical interventions for disease control.